< Back to previous page

Publication

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patientU+2010reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUSU+201024 and SINUSU+201052 studies

Journal Contribution - Journal Article

Journal: CLINICAL AND EXPERIMENTAL ALLERGY
ISSN: 1365-2222
Issue: 2
Volume: 52
Pages: 244 - 249
Publication year:2022
Accessibility:Closed